• 1. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 5. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Introduction to (3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester (CAS No. 2380415-50-7)

The compound (3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester, identified by its CAS number 2380415-50-7, is a specialized organic molecule with significant implications in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine class of heterocyclic structures, which are widely recognized for their role in the synthesis of biologically active agents. The stereochemical configuration at the 3-position, specifically the (S) configuration, adds a layer of complexity and importance to its potential applications in drug development.

In recent years, there has been a growing interest in chiral piperidine derivatives due to their unique pharmacological properties. The presence of a hydroxyl group at the 3-position and a tert-butyl ester moiety at the 1-carboxylic position enhances the molecule's solubility and stability, making it a promising candidate for further investigation. The tert-butyl ester group is particularly noteworthy as it can be easily hydrolyzed under specific conditions, potentially releasing the free carboxylic acid for further functionalization or biological evaluation.

One of the most compelling aspects of this compound is its potential role in the development of novel therapeutic agents. Piperidine derivatives have been extensively studied for their activity in various therapeutic areas, including central nervous system (CNS) disorders, cardiovascular diseases, and anti-inflammatory applications. The (S)-configuration of this compound suggests that it may exhibit high enantiomeric purity, which is crucial for achieving optimal pharmacological effects while minimizing unwanted side reactions.

Recent advancements in synthetic chemistry have enabled more efficient and scalable production methods for complex piperidine derivatives. The synthesis of (3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester has been refined to ensure high yield and purity, making it more accessible for academic and industrial research. These improvements have opened up new avenues for exploring its biological activity and potential therapeutic applications.

From a biochemical perspective, the hydroxyl group at the 3-position can participate in hydrogen bonding interactions, which are critical for binding to biological targets such as enzymes and receptors. This feature makes the compound an attractive scaffold for designing molecules with specific binding affinities. Additionally, the tert-butyl ester group can serve as a protective group during synthetic transformations, allowing for selective modifications at other sites on the molecule.

The pharmaceutical industry has shown particular interest in developing prodrugs that can be converted into active pharmaceutical ingredients (APIs) within the body. The tert-butyl ester group in (3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester makes it an excellent candidate for such applications. Upon enzymatic hydrolysis, the ester can be cleaved to release the free carboxylic acid, which may then undergo further metabolic transformations to yield the active drug form.

In vitro studies have begun to explore the pharmacological profile of this compound. Initial experiments suggest that it may exhibit inhibitory activity against certain enzymes and receptors relevant to various diseases. For instance, its structure resembles known scaffolds that have shown promise in treating neurological disorders such as Parkinson's disease and Alzheimer's disease. Further research is needed to fully elucidate its mechanism of action and therapeutic potential.

The synthesis of chiral piperidine derivatives often presents significant challenges due to their sensitivity to stereochemical changes during reaction conditions. However, modern synthetic methodologies have made significant strides in preserving enantiomeric purity throughout complex synthetic routes. The production of (3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester exemplifies these advancements, demonstrating how stereochemically controlled synthesis can be achieved on a larger scale.

Future directions in research may include exploring derivative compounds generated by modifying different functional groups within the piperidine core. By systematically altering substituents such as hydroxyl groups or ester moieties, researchers can fine-tune the pharmacological properties of these molecules to achieve desired outcomes. The versatility of (3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester makes it a valuable starting point for such explorations.

The broader impact of this compound extends beyond academic research into practical applications in drug development pipelines. Companies specializing in custom synthesis are increasingly offering services to produce complex chiral intermediates like this one under contract manufacturing agreements (CMAs). This trend underscores the growing importance of specialized organic compounds in modern pharmaceutical innovation.

In conclusion,(3S)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester (CAS No. 2380415-50-7) represents a significant advancement in pharmaceutical chemistry with potential applications across multiple therapeutic areas. Its unique structural features and stereochemical configuration make it an intriguing candidate for further investigation into novel drug development strategies. As synthetic methodologies continue to evolve, compounds like this one will play an increasingly vital role in advancing medical science.

• 1189570-45-3(tert-butyl (5R)-5-hydroxy-3,3-dimethylpiperidine-1-carboxylate)
• 110408-32-7(2-Methyl-2-propanyl 3-hydroxy-3-methyl-1-piperidinecarboxylate)
• 2413846-73-6(tert-butyl (3R,5R)-3-hydroxy-5-methyl-piperidine-1-carboxylate)
• 1104083-27-3(tert-butyl 3-hydroxy-3-methyl-piperidine-1-carboxylate)
• 184969-12-8(1-Boc-4-(3-Hydroxypiperidin-1-ylmethyl)piperidine)
• 1932597-68-6(tert-butyl (3R,5S)-3-hydroxy-5-methyl-piperidine-1-carboxylate)
• 2409588-29-8(tert-butyl (3S,5S)-3-hydroxy-5-methyl-piperidine-1-carboxylate)
• 955028-51-0(tert-butyl cis-3-hydroxy-5-methyl-piperidine-1-carboxylate)
• 2198241-78-8((3R)-3-Hydroxy-3-methyl-piperidine-1-carboxylic acid tert-butyl ester)
• 1909294-25-2(tert-butyl (3S,5R)-3-hydroxy-5-methyl-piperidine-1-carboxylate)